RxDoctor Payments Data

Ateeq Haseeb, MD

Neurology with Special Qualifications in Child Neurology · Toledo, OHNPI 1194923060

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Livanova USA, Inc. accounts for 76.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $3,658 and has fallen 71.1% since, to $1,057 in 2025.

$9,119in general payments, 2019–2025

Across 155 payments — averaging $58.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$7K
  • Supernus Pharmaceuticals, Inc.$338
  • Neurelis, Inc.$283
  • Jazz Pharmaceuticals Inc.$213
  • UCB, Inc.$186
  • Acadia Pharmaceuticals Inc$120
  • plus $1K from 21 others

What the payments were for

  • Speaking & faculty fees$4,65651%
  • Travel & lodging$8309%
  • Food & beverage$3,58739%
  • Education$461%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,119 in reported general payments places this provider in the 75th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio

Medicare billing

Part B allowed, 2024
$77,930
Medicare patients
327
Services billed
1,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin18$1,967
Levetiracetam112$1,514
Memantine Hcl45$1,092
Phenytoin26$416
Guanfacine Hcl ErGuanfacine Hcl15$233
Benztropine Mesylate12$170
Tizanidine Hcl53$159
Risperidone11$139
Lorazepam36$125
Phenobarbital12$92
Sertraline Hcl11$15

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →